H49.812
Kearns-Sayre syndrome, left eye
Clinical Classification Guidelines
Medical Intelligence & Overview
Kearns-Sayre syndrome (KSS) is a rare genetic disorder that affects multiple parts of the body, especially the eyes and muscles. When associated with the left eye, the condition involves specific visual and muscular challenges. This syndrome typically develops during childhood or early adulthood and can lead to progressive symptoms that impact daily life. Understanding the features, causes, and potential effects of KSS can help in managing the condition effectively.
Causes & Symptoms
Clinical Causes: Mutations in mitochondrial DNA, which are inherited from the mother Genetic mutations affecting mitochondrial function, leading to energy production issues in cells No known environmental cause; the disorder is primarily genetic in origin
Key Symptoms: Progressive vision loss, often involving ptosis (drooping of the eyelid) Retinal pigmentary changes, leading to visual deterioration on the affected side Muscle weakness and weakness in other voluntary muscles Cardiac conduction defects, which can affect heart rhythm Hearing loss Excessive fatigue Balance problems and coordination difficulties Short stature and extraocular muscle involvement
Diagnostic & Treatment
Diagnosis Path: Diagnosis of Kearns-Sayre syndrome involves a combination of clinical evaluations and laboratory tests. Eye examinations reveal characteristic retinal changes and eyelid drooping. Electromyography can assess muscle function. Blood tests may show elevated levels of lactate and pyruvate, indicating mitochondrial dysfunction. A muscle biopsy identifying defective mitochondria and genetic testing of mitochondrial DNA can confirm the diagnosis. Since it affects multiple systems, a comprehensive evaluation including heart and neurological assessments is essential.
Treatment Protocols: Regular eye examinations and visual support such as glasses or low-vision aids Surgical intervention for eyelid ptosis if it interferes significantly with vision Monitoring and managing cardiac conduction defects, which may require pacemaker implantation Physical therapy to maintain muscle strength and mobility Hearing aids if hearing loss is present Supportive therapies addressing fatigue and neurological symptoms Genetic counseling for affected individuals and their families
Clinical Advice & FAQs
Billing Guidance
Is H49.812 a billable ICD-10 code?
Yes, H49.812 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H49.812?
Clinical documentation must specify the nature of Kearns-Sayre syndrome, left eye and any associated comorbidities for accurate reporting.
Cite this Clinical Reference